For the Inventor, By the Inventor

Enter assignee name

Austin, TX, United States of America

Molecular Templates, Inc.

USPTO Granted Patents = 26

CIPO Patents = 10

EPO Patents = 18

Forward Citations = 79

Loading Chart...

Loading Chart...

32 inventors (with patents filed for the assignee):

Erin Willert (20 out of 22 patents)

Eric Poma (20 out of 20 patents)

Jason Kim (8 out of 8 patents)

4. Jack Higgins (8 out of 8 patents)

5. Sangeetha Rajagopalan (5 out of 5 patents)

6. Jensing Liu (4 out of 4 patents)

7. Garrett Lee Robinson (3 out of 3 patents)

8. Brigitte Brieschke (3 out of 3 patents)

9. Rodney Flores-Lefranc (3 out of 3 patents)

10. Hilario Ramos (3 out of 3 patents)

11. Jian-Xin Duan (3 out of 18 patents)

12. Mark D Matteucci (3 out of 65 patents)

13. Richard Shimkets (2 out of 3 patents)

14. Crystal Jackson (2 out of 3 patents)

15. Thomas Vincent (2 out of 3 patents)

26 patents: Sort by Forward Citations

1. 12180284 - Clinical methods for use of a PD-L1-binding molecule comprising a Shiga toxin effector (2024-12-31),

2. 12180262 - CD38-binding proteins comprising de-immunized Shiga toxin A subunit effectors (2024-12-31),

3. 12065469 - De-immunized Shiga toxin a subunit effector polypeptides for applications in mammals (2024-08-20),

4. 12037367 - MHC class I epitope delivering polypeptides (2024-07-16),

5. 11918649 - PD-L1-binding molecules comprising Shiga toxin a subunit scaffolds (2024-03-05),

6. 11857628 - Shiga toxin A subunit effector polypeptides, Shiga toxin effector scaffolds, and cell-targeting molecules for site-specific conjugation (2024-01-02),

7. 11713347 - CD38-binding proteins comprising de-immunized Shiga toxin A subunit effectors (2023-08-01),

8. 11406692 - Cell-targeting molecules comprising de-immunized, Shiga toxin a subunit effectors and CD8+ t-cell epitopes (2022-08-09),

9. 11389542 - Shiga toxin a subunit effector polypeptides, Shiga toxin effector scaffolds, and cell-targeting molecules for site-specific conjugation (2022-07-19),

10. 11365223 - De-immunized, Shiga toxin a subunit scaffolds and cell-targeting molecules comprising the same (2022-06-21),

11. 11312751 - MHC class I epitope delivering polypeptides (2022-04-26),

12. 11248061 - Multivalent CD20-binding molecule comprising Shiga toxin A subunit effector polypeptides and enriched compositions thereof (2022-02-15),

13. 11225509 - HER2-targeting molecules comprising de-immunized, Shiga toxin A subunit scaffolds (2022-01-18),

14. 11142584 - CD20-binding proteins comprising Shiga toxin A subunit effector regions for inducing cellular internalization and methods using same (2021-10-12),

15. 11136395 - PD-L1 -binding molecules comprising Shiga toxin A subunit scaffolds (2021-10-05),

Molecular Templates, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of targeted biologic therapeutics for the treatment of cancer. Using its proprietary engineered toxin body (ETB) platform, Molecular Templates creates differentiated, targeted therapies that utilize the body’s immune system to selectively eliminate tumor cells. The company’s lead product candidate, MT-3724, is being evaluated in multiple clinical trials for the treatment of non-Hodgkin lymphoma and other advanced solid tumors.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

26 Patents

#111 in Austin, TX

#728 in Texas

#12,424 in US

#24,051 in the World

Austin, TX, United States of America

Molecular Templates, Inc.

Forward Citations = 79

32 inventors:

Erin Willert (20 out of 22 patents)

Eric Poma (20 out of 20 patents)

Jason Kim (8 out of 8 patents)

4. Jack Higgins (8 out of 8 patents)

5. Sangeetha Rajagopalan (5 out of 5 patents)

Please report any incorrect information to support@idiyas.com

Loading…